Company: PCRX
Filing Date: 2025-08-05
Form Type: 10-Q
Source: 0001396814-25-000102
Chunk: 133

Company: Pacira BioSciences, Inc.
Filing Date: 2025-08-05
Form: 10-Q
Item: Part II, Item 1A
Chunk 133
---
10b5-1 under the Exchange Act. The share repurchase program may be suspended or discontinued at any time by the Company and has an expiration date of December 31, 2026.

The timing of any repurchases and the actual number of shares repurchased will depend on a variety of factors, including our stock price, corporate and regulatory requirements, tax implications, restrictions under our debt obligations, other uses for capital, impacts on the value of remaining shares, and market and economic conditions.

Refer to Note 11, Stockholders’ Equity, to our condensed consolidated financial statements included herein for more information on our share repurchases.

Item 3. DEFAULTS UPON SENIOR SECURITIES

None.

Item 4. MINE SAFETY DISCLOSURES

Not applicable.

Pacira BioSciences, Inc.  |  Q2 2025 Form 10-Q  |  Page 57

Table of Contents

Item 5. OTHER INFORMATION

Rule 10b5-1 Trading PlansThe following table shows the “Rule 10b5-1 trading arrangements” and “non-Rule 10b5-1 trading arrangements” (as each term is defined in Item 408(a) of Regulation S-K) adopted by our directors and executive officers during the quarter ended June 30, 2025. No trading arrangements were terminated by our directors and executive officers during the quarter ended June 30, 2025. Trading ArrangementName and PositionActionDateRule 10b5-1*Non-Rule10b5-1**Total Number ofShares to be SoldExpirationDateAbraham CeesayDirectorAdopt6/3/2025x2,3549/4/2025Shawn M. CrossChief Financial OfficerAdopt6/9/2025xTo Be Determined (1)5/29/2026Lauren RikerPrincipal Accounting OfficerAdopt6/13/2025xTo Be Determined (1) (2)2/3/2026 * Intended to satisfy the affirmative defense of Rule 10b5-1(c).** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).(1) The aggregate number of shares to be sold pursuant to the trading arrangements listed above are dependent on the amount of tax withholding required upon the vesting of restricted stock units, and, therefore, is indeterminable at this time.(2) Includes shares to be sold which are scheduled to be